Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4A | P27815 | 1/20 | 0.64 |
| ▸ | LMNA | P02545 | 2/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | USP2 | O75604 | 1/20 | 0.48 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10338405 | 1.00 | PDE4A (0.64) | PDE4ALMNATDP1L3MBTL1USP2 | |
| SCHEMBL16280148 | 1.00 | PDE4A (0.64) | PDE4ALMNATDP1L3MBTL1USP2 | |
| SCHEMBL20591201 | 1.00 | PDE4A (0.64) | PDE4ALMNATDP1L3MBTL1USP2 | |
| SCHEMBL13518379 | 1.00 | PDE4A (0.64) | PDE4ALMNATDP1L3MBTL1USP2 | |
| SCHEMBL15121487 | 1.00 | PDE4A (0.64) | PDE4ALMNATDP1L3MBTL1USP2 | |
| SCHEMBL15121486 | 1.00 | PDE4A (0.64) | PDE4ALMNATDP1L3MBTL1USP2 | |
| SCHEMBL725570 | 1.00 | PDE4A (0.64) | PDE4ALMNATDP1L3MBTL1USP2 | |
| SCHEMBL28350552 | 0.98 | PDE4A (0.67) | PDE4ALMNATDP1L3MBTL1USP2 | |
| SCHEMBL8343201 | 0.98 | PDE4A (0.67) | PDE4ALMNATDP1L3MBTL1USP2 | |
| SCHEMBL29356160 | 0.98 | PDE4A (0.67) | PDE4ALMNATDP1L3MBTL1USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10717718-B2 | 5-azido-5-deoxy-2 :3-isopropylidene-D-arabinose compounds; their method of manufacture and their use for the synthesis of ARA-N3, KDO-N3 and 4EKDO-N3 | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2020-07-21 | — | — | US | claimed |
| US-20200209238-A1 | OPTIMIZING DIAGNOSTICS FOR GALACTOFURANOSE CONTAINING ANTIGENS | THE JOHNS HOPKINS UNIVERSITY | 2020-07-02 | — | — | US | claimed |
| US-20180370942-A1 | NEW 5-AZIDO-5-DEOXY-2 :3-ISOPROPYLIDENE-D-ARABINOSE COMPOUNDS; THEIR METHOD OF MANUFACTURE AND THEIR USE FOR THE SYNTHESIS OF ARA-N3, KDO-N3 AND 4EKDO-N3 | CENTRE NATIONAL DE LA RECHERCHE SCIENTIQUE (CNRS) (FR) | 2018-12-27 | — | — | US | claimed |
| US-20230173064-A1 | DETOXIFIED LIPOPOLYSACCHARIDES (LPS), NATURALLY NON-TOXIC LPS, AND USES THEREOF | HEPHAISTOS-PHARMA (FR) | 2023-06-08 | — | — | US | disclosed |
| EP-4103726-A1 | KDO-FREE PRODUCTION HOSTS FOR OLIGOSACCHARIDE SYNTHESIS | Inbiose N.V. (BE) | 2022-12-21 | — | — | EP | disclosed |
| US-20220062849-A1 | METHOD AND DEVICE FOR PRODUCING SACCHARIDES AND SACCHARIDE ARRAYS | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2022-03-03 | — | — | US | disclosed |
| WO-2021160828-A1 | KDO-FREE PRODUCTION HOSTS FOR OLIGOSACCHARIDE SYNTHESIS | INBIOSE N.V. (BE) | 2021-08-19 | — | — | WO | disclosed |
| US-10717718-B2 | 5-azido-5-deoxy-2 :3-isopropylidene-D-arabinose compounds; their method of manufacture and their use for the synthesis of ARA-N3, KDO-N3 and 4EKDO-N3 | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2020-07-21 | — | — | US | disclosed |
| US-20200209238-A1 | OPTIMIZING DIAGNOSTICS FOR GALACTOFURANOSE CONTAINING ANTIGENS | THE JOHNS HOPKINS UNIVERSITY | 2020-07-02 | — | — | US | disclosed |
| US-10624984-B2 | Aptamer-modified polymeric materials for the binding of factors in a wound environment | KCI LICENSING, INC. (US) | 2020-04-21 | — | — | US | disclosed |
| US-10359398-B2 | Method for determining carbohydrates structure | MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V. (DE) | 2019-07-23 | — | — | US | disclosed |
| US-20170246341-A1 | AMINE-FUNCTIONALIZED POLYMERIC COMPOSITIONS FOR MEDICAL DEVICES | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2017-08-31 | — | — | US | disclosed |
| US-20170190828-A1 | SULFHYDRYL-FUNCTIONALIZED POLYMERIC COMPOSITIONS FOR MEDICAL DEVICES | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2017-07-06 | — | — | US | disclosed |
| US-20160346421-A1 | APTAMER-MODIFIED POLYMERIC MATERIALS FOR THE BINDING OF FACTORS IN A WOUND ENVIRONMENT | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2016-12-01 | — | — | US | disclosed |
| US-20160131649-A1 | MICROBIAL GLYCANS AS A TARGET OF HUMAN INTELECTIN | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2016-05-12 | — | — | US | disclosed |
| US-20140179624-A1 | CYTOPROTECTIVE DERIVATIVES OF AVICIN D AND METHODS OF MAKING AND USING THEREOF | RESEARCH DEVELOPMENT FOUNDATION (US) | 2014-06-26 | — | — | US | disclosed |
| US-20080075742-A1 | Compositions Comprising Fetal Hemoglobin and Bacterial Endotoxin and Optionally Additional Fetal Liver Components | Clinique La Prairie S.A. (CH) | 2008-03-27 | — | — | US | disclosed |
| US-6833451-B2 | Phenol, water solvent extraction using a protease | PHARMA-ZENTRALE GMBH (DE) | 2004-12-21 | — | — | US | disclosed |
| EP-0829104-A1 | HIGH ENERGY DENSITY VANADIUM ELECTROLYTE SOLUTIONS, METHODS OF PREPARATION THEREOF AND ALL-VANADIUM REDOX CELLS AND BATTERIES CONTAINING HIGH ENERGY VANADIUM ELECTROLYTE SOLUTIONS | UNISEARCH LIMITED (AU) | 1998-03-18 | — | — | EP | disclosed |
| WO-1996035239-A1 | HIGH ENERGY DENSITY VANADIUM ELECTROLYTE SOLUTIONS, METHODS OF PREPARATION THEREOF AND ALL-VANADIUM REDOX CELLS AND BATTERIES CONTAINING HIGH ENERGY VANADIUM ELECTROLYTE SOLUTIONS | UNISEARCH LIMITED (AU) | 1996-11-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140179624-A1 | CYTOPROTECTIVE DERIVATIVES OF AVICIN D AND METHODS OF MAKING AND USING THEREOF | FANCD2, NQO1, BAX | PDE4A 3208/4885LMNA 863/4885TDP1 3545/4885 |
| US-20180370942-A1 | NEW 5-AZIDO-5-DEOXY-2 :3-ISOPROPYLIDENE-D-ARABINOSE COMPOUNDS; THEIR METHOD OF MANUFACTURE AND THEIR USE FOR THE SYNTHESIS OF ARA-N3, KDO-N3 AND 4EKDO-N3 | GALE, ALDOA, DERA | PDE4A 1614/4885LMNA 2200/4885TDP1 4634/4885 |
| US-20230173064-A1 | DETOXIFIED LIPOPOLYSACCHARIDES (LPS), NATURALLY NON-TOXIC LPS, AND USES THEREOF | LRBA, LITAF, CD14 | PDE4A 2080/4885LMNA 336/4885TDP1 4723/4885 |
| US-10624984-B2 | Aptamer-modified polymeric materials for the binding of factors in a wound environment | SDF4, PCLAF, CCL2 | PDE4A 695/4885LMNA 3007/4885TDP1 759/4885 |
| US-20220062849-A1 | METHOD AND DEVICE FOR PRODUCING SACCHARIDES AND SACCHARIDE ARRAYS | MGAM, SORD, FUT5 | PDE4A 2311/4885LMNA 4832/4885TDP1 2731/4885 |
| US-10717718-B2 | 5-azido-5-deoxy-2 :3-isopropylidene-D-arabinose compounds; their method of manufacture and their use for the synthesis of ARA-N3, KDO-N3 and 4EKDO-N3 | GALE, ALDOA, DERA | PDE4A 1898/4885LMNA 1793/4885TDP1 4609/4885 |
| US-20160131649-A1 | MICROBIAL GLYCANS AS A TARGET OF HUMAN INTELECTIN | HINT1, DERL1, ENGASE | PDE4A 4264/4885LMNA 2955/4885TDP1 2856/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.